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Abstract
Purpose: To investigate the role of ischemic preconditioning (IPC) and pentoxifylline (PTX) in 
intestinal mucosa ischemia/reperfusion injury (IR). 
Methods: Thirty rats were assigned to 5 groups (N=6): (CG): no clamping of the superior 
mesenteric artery (90 min.); (IR-SS): saline + ischemia (30 min.) + reperfusion (60 min.); (IR-
PTX): PTX + ischemia (30min.) + reperfusion (60 min.); (IPC-IR-SS): 5 min. of ischemia + 5 
minutes of reperfusion (IPC) + saline + ischemia (30 min.) + reperfusion (60 min.);  (IPC-IR-PTX 
): 5 min. of ischemia + 5 min. of reperfusion (IPC) + PTX + 30 min. of I + 60 minutes of R. 
Results: The IR-PTX, IPC-IR-SS and IPC-IR-PTX groups had significantly lower scores of mucosa 
damage than the IR-SS group. IR-PTX group showed higher scores than the IPC-IR-PTX group, 
in accordance with the hypothesis of a favorable effect of IPC alone or in association with 
PTX. Additionally, IPC-IR-SS had a higher damage score than the IPC-IR-PTX. The villi height 
and crypt depth were similar in all groups. The villi height in the IR-SS was significantly lower. 
Conclusion: Ischemic preconditioning or pentoxifylline alone protect the intestinal mucosa 
from ischemia/reperfusion injury. However, they do not have a synergistic effect when applied 
together.
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although a large number of signaling pathways 
underlying IPC have been identified in the past 
30 years8,9,11,12.
 On the other hand, the drugs 
pentoxifylline (PTX), a methylxanthine 
derivative of theobromine, has been proposed 
to decrease the deleterious effects of IR4,12-14. 
In clinical use for the 30 past years as well, it 
improves the rheological properties of the 
blood in numerous ways: decreasing plasma and 
whole blood viscosity, in large measure owing 
to a reduction in plasma fibrinogen; increasing 
erythrocyte distensibility and suppressing 
erythrocyte aggregation; diminishing platelet 
aggregation; and increasing blood filterability 
by suppressing neutrophil activation13.
 The cumulative effect of a reduction 
in plasma viscosity, an increase in erythrocyte 
flexibility, and a suppression of neutrophil 
activation lead to an improvement in capillary 
blood flow, particularly in vascular beds 
downstream from arterial flux damage. 
Pentoxifylline also exerts anti-inflammatory 
and antioxidant effects. The antioxidant effects 
appear primarily attributable to decreased 
neutrophil activation, as activated neutrophils 
generate superoxide via NADPH oxidase. It 
lowers the plasma levels of proinflammatory 
cytokines such as tumor necrosis factor (TNF) 
α, interleukin (IL) 1 and IL-612-14. The biologic 
pathways underlying these various effects 
remain rather murky.
 Both procedures have common 
biological pathways and have not yet been 
investigated together. Therefore, we decided to 
investigate a possible additive protective effect 
through the use of IPC and PTX on intestinal 
mucosa using an intestinal IR model in rats.
 ■ Methods
 Thirty male Wistar-EPM1 rats, 250 to 
 ■ Introduction
 Organs subjected to extended 
periods of ischemia (I) during major surgical 
procedures and reperfusion (R) following 
organ revascularization experience major 
oxidative stress conditions1-3. In the intestine, 
IR injuries are associated with a number of 
clinical conditions, which may include acute 
mesenteric ischemia, intestinal obstruction, 
and necrotizing colitis4,5. IR injury can also occur 
because of collapse of systemic circulation, as 
in hypovolemic and septic shock1.  In addition, 
intestinal transplantation is also a situation 
in which the cascade of deleterious events 
associated with IR is relevant1,4,5.
 Ischemic preconditioning (IPC) is an 
intrinsic process whereby repeated short 
episodes of ischemia protect the organ 
against a subsequent prolonged ischemic 
insult4-7. Several reports have described the 
effects of IPC on the reduction of apoptosis of 
epithelial cells4,5,7-9, structural protection4,10,11 
and preservation of intestinal contractility10. 
In brief, the IPC stimulus, made up of cycles 
of brief ischemia and reperfusion, initiates 
production of a number of autacoids (such 
as acetylcholine, adenosine, bradykinin, 
endothelin, and opioids)11. These substances 
bind to their respective receptors on the plasma 
membrane to stimulate a number of signaling 
pathways that convey a protective signal to 
the mitochondria11,12, wherein a signaling of 
reactive oxygen species (ROS) occurs2,11,12. 
They activate protein kinases such as Akt, 
Erk1/2, protein kinase C, and tyrosine kinase, 
which provide the ‘memory’ in response to 
the subsequent and prolonged ischemia. This 
process allows the protective effect to last up to 
2–3 hours. Despite intensive investigation, the 
actual mechanisms that mediate this protective 
effect remain incompletely understood, 
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300g, from the Center for the Development of 
Experimental Models for Medicine and Biology 
(CEDEME, Sao Paulo-SP, Brazil) remained under 
controlled temperature (23°C), 50% humidity 
on, and light conditions with a 12-hour light/
dark. The animals were housed in a controlled 
environment at the Experimental Surgery 
Department of UNIFESP. The individual cages 
had dimensions of 40 cm×30 cm×25 cm and, 
which were covered with previously autoclaved 
wood shavings. Thad ad libitum access to water 
and balanced feed. All procedures involving 
anaesthesia and euthanasia were performed 
according to followed the guidelines of the 
National Council Animal Experimentation 
Control (SBCAL/COBEA – Brazil http://www.
cobea.org.br/).
 The animals were anesthetized by 
80mg/kg ketamine (Dopalen®, Sespo Indústria 
Comércio, Paulínea-SP, Brazil) and 10mg/kg 
xylazine (Dopaser®, Herpate Callieri, Juatuba-
MG, Brazil) and were subjected to median 
laparotomy. Then, the superior mesenteric 
vessels were identified and clamped according 
to the group. The femoral vein was dissected 
and catheterized for infusions of drug (80mg/
kg pentoxifylline, Sigma Aldrich, Sao Paulo-SP, 
Brazil) or 0.9% saline solution (in control group) 
5 min before sustained ischemia. Afterwards, 
the animals were randomly distributed into 
five groups: the control group (CG) received 
anesthesia + laparotomy + no clamping of 
the superior mesenteric artery (time elapsed 
90 minutes), the IR-SS group received saline 
+ 30 minutes of ischemia + 60 minutes of 
reperfusion, the IR-PTX group received 
pentoxifylline + 30 minutes of ischemia + 60 
minutes of reperfusion, the IPC-IR-SS group 
received five minutes of ischemia + five 
minutes of reperfusion (preconditioning) + 
saline + 30 minutes of ischemia + 60 minutes of 
reperfusion, and the IPC-IR-PTX group received 
five minutes of ischemia + five minutes of 
reperfusion (preconditioning) + pentoxifylline 
+ 30 minutes of ischemia + 60 minutes of 
reperfusion.
 At the end of the reperfusion period, 
one intestinal samples were collected 20 cm 
from the duodenum-jejunum flexure, opened 
longitudinally, gently washed in saline solution, 
and fixed in 10% formaldehyde phosphate-
buffered solution. The tissue samples were 
then processed for paraffin embedding and 
subsequently stained with hematoxylin 
and eosin (H.E.) for histological analysis.  A 
Scanner (3D HISTECH®, Biogen, Sao Paulo-
SP, Brazil) captured all images of histological 
slides. The images were analyzed by specific 
software (Case Viewer®, 3D Histech Biogen, 
Sao Paulo-SP, Brazil; magnification x20, x40, 
x50). An independent pathologist, who had no 
knowledge of the origins of the experimental 
groups, undertook the histological study. We 
used the score for the damage based on the 
criteria of Chiu et al.15: Grade 0 - mucosa without 
any histological alteration; Grade 1- intestinal 
villous well constituted, no cellular lysis and 
no inflammatory process, but subepithelial 
Grünhagen space present;  Grade 2 - cellular 
lysis, presence of subepithelial Grünhagen 
space and distances among intestinal villous 
increased; Grade 3 - destruction of the tip 
portion of the villous, capillaries dilated and 
presence of inflammatory cells; Grade 4 - 
structural destruction of intestinal villous, 
presence of inflammatory cells and necrotic 
material, hemorrhagic areas and loosening 
of the tip of the superficial intestinal mucosa 
villous; Grade 5 - destruction of the intestinal 
mucosa, no glandular structures preserved 
and presence of amorphous substance at the 
submucosal region.  The data were expressed 
by mean ± standard error (x ± se). The 
difference among the groups, a Kruskal-Wallis 
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non-parametric test was followed by Bonferroni 
post hoc comparison test, and processed by 
statistic software (STAT 9.4, Stat Plus de Analyst 
Soft Inc.)
 The quantitative measurement of the 
thickness of the intestinal wall was to switch 
the length of the villi from its outermost layer 
(serous) to its most prominent summit in the 
intestinal lumen. The standard of measurement 
for the crypts was the depth from the serosa 
to the bottom of the crypt. Ten fields were 
randomly chosen, for a total of 60 crypts and 
60 villi, with the criteria of identifying villi in 
a visible field and a defined epithelium for 
reading measurements through the program 
(Case Viewer, 3D HISTECH), expressed in 
micrometers (μm), The results were expressed 
as the means ± standard error, and analyses 
of variance with repeated measures (ANOVA) 
followed Bonferroni post hoc comparison test. 
The level of rejection of the null hypothesis 
was set to 5% (P ≤ 0.05). All calculations were 
performed using Stat software version 9.4®.
 ■ Results
 The histological sections in Figure 1 
allowed us to verify the morphological changes 
in the intestinal mucosal layer in each of the 
five study groups.
 The control group showed intact villi 
without disruption of enterocytes and no debris 
in the lumen (Figure1, A-GC). However, in the 
IR-SS group, in which intravenous injection of 
saline was followed by 30 minutes ischemia 
and 60 minutes of reperfusion, damage was 
evident (Figure 1, B-IR+SS). Destruction of the 
intestinal villi architecture, interstitial swelling, 
hemorrhagic foci and cellular debris in the 
intestinal lumen were observed. In the IR-PTX 
group (Figure 1C), although the villi remained 
intact without cell lysis or inflammation, spaces 
(Grünhagen spaces) were present (Figure 
1, C-IR+PTX). The IPC+IR+SS (Figure 1D) and 
IPC+IR+PTX (Figure 1E) groups showed similar 
findings, with cell lysis at the apex of the villi, 
interstitial vasodilatation, increased spacing 
among the villi and mild edema.
Figure 1 - Histological features of the rat intestinal mucosa. A, CG: total integrity of the epithelium. B, IR+SS 
group showed loss of the architecture of the intestinal villi and the presence of interstitial swelling (*). C, 
IR+PTX group, had villi with normal structures and without cell lysis or inflammation, although subepithelial 
spaces (Grünhagen spaces) were present (arrows). The IPC+IR+SS (D) and IPC+IR+PTX (E) groups had similar 
findings with cell lysis at the apex of the villi (*) and interstitial vasodilatation (scale bar 20µm H.E. staining).
 The qualitative histological evaluation 
was complemented by the lesion score based 
on the criteria of Chiu et al.15. Figure 2 shows 
the scores among the five groups and their 
statistical significance. The IR-PTX (1.39 ± 0.25), 
PCI-IR-SS (1.28 ± 0.13), and IPC-IR-PTX (1.06 ± 
0.13) groups showed significantly lower scores 
than the IR-SS (3.67 ± 0.42) group. These 
findings are consistent with a favorable effect 
of PTX and PCI alone or in combination. On 
the other hand, the IR-PTX group had higher 
scores than the IPC-IR-PTX groups, which is in 
accordance with the hypothesis of a favorable 
effect of IPC alone or in association with PTX. 
The IPC-IR-SS group had a higher damage score 
than the IPC-IR-PTX group.
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Figure 2 - Intestinal mucosal injury scores. Statistical 
analyses for all studied groups were performed 
using the Kruskal-Wallis (H=25.45, P<0.0001) and 
pos hoc Bonferroni tests. (*) Statistically significant 
values: was represent in charts.
 The villi height and crypt depth (Figures 
3 and 4, respectively) were standard in the 
control group. Figure 3 shows that the villi 
height in the IR-SS group (565.58 ± 139.31) 
was significantly lower than the control group 
(808.38 ± 185.48), making it clear that intestinal 
IR promoted damage to the intestinal mucosa. 
On the other hand, villi height in the IR-PTX 
(790.35 ± 171.52), IPC-IR-SS (875.35 ± 150.62) 
and IPC-IR-PTX (916.76 ± 191.60) groups was 
significantly higher (P=0. 0088, P=0.0002, P< 
0.0001 respectively) than that in the IR-SS 
group and had values similar to the standard 
values seen in the control group. In addition, 
villi height did not differ among the IR-PTX, IPC-
IR-SS and IPC-IR-PTX groups, indicating that 
the combination of IPC and PTX (IPC-IR-PTX 
group) did not differ significantly from these 
interventions alone (Figure 3). Crypt depth 
(Figure 4) was similar among the groups.
 
Figure 3 – Mean and standard error, and 
difference entre means groups the ANOVA One–
WAY (F=10.45, P<0.0001) the rat intestinal villi 
height measurements was different, and pos hoc 
Bonferroni test. (*) Analyze by pairs de difference 
statistically significant values was representing in 
the chart.
 
Figure 4 - Mean and standard error, 95% confidence 
interval by factor and F Test from the analysis 
of variance (ANOVA, F=0.67) was mayor than 
others groups P>0. 61 of rat intestinal crypt depth 
measurements.
 ■ Discussion
 This study demonstrated that PTX or 
IPC can protect against ischemic damage in the 
small intestine in rats. Animals treated with PTX 
(80 mg/kg before ischemia) had high scores 
for mucosa preservation, high villi height and 
similar crypt depth to the IR group. Similarly, 
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IPC (5 minutes of ischemia and 5 minutes 
reperfusion before 30 minutes of sustained 
ischemia) also protected the mucosa and the 
anatomical structure of the villi. However, the 
combination of both did not show an additive 
effect. The results of the combination were the 
same as the results of each procedure used 
alone.
 Several clinical conditions are associated 
with IR injuries in the intestine and relevant 
morphological changes were determined for 
those conditions6,9,16-18. Epithelial detachment 
of the villi was previously described in the 
small intestine of rats using IR periods of 60 
min and 90 min9,18-20. The results obtained in 
the present study were in accordance with 
these earlier observations.
 The histological analyses showed 
detachment of epithelial cells (progressively 
worsening from the base to the top of the villi), 
sub-epithelial edema, and mild changes in the 
morphological structure of the submucosa with 
leukocyte infiltration. The mucosa damage was 
partially abolished with PTX treatment, with 
the IPC procedure, and with both interventions.
 It is known that villus height and crypt 
depth vary according to the small intestine 
segment4,9,20,21. We focused the sample 
collection on the 20 cm area away from the 
duodenum-jejunum junction. In CG, the villi 
maintained their normal structure with an 
elongated axis and the lining with the intact 
enterocytes. There was no inflammatory 
edema or leucocyte infiltration on the axis or 
detachment of enterocytes. In the intestinal 
lumen, no cellular debris was detected.
 The morphological changes maintained 
a standard structural derangement that 
started from the distal portion of the villi to the 
proximal portion, which was evident in the IR-
SS group. The greatest intensity of the lesion 
led to detachment of the mucosa and the 
appearance of debris in the intestinal lumen.
 The height of villi varies within each 
intestinal region5,6,9,20,21. In animals subjected 
only to the IR procedure, the villous height 
was lower, indicating tissue damage. In the 
IR-PTX group, we found that the villi were 
well preserved, the leukocytes were less 
conspicuous, and the capillaries were dilated. 
Corroborating our findings, previous reports 
described more severe villous lesions in 
animals subjected to IR without any treatment 
compared to animals subjected to PTX 
treatment13,17,18,22-25.
 Other reports using PTX at 
concentrations less than or equal to the 
concentrations used in this study have reported 
the preservation of the villi in the intestinal 
epithelium, similar to the results described 
here13,17,18,22-26.
 PTX showed a favorable effect by 
decreasing the score of the degree of cell 
damage. The height of the villi and the depth of 
the crypts were also preserved. The discovery 
that PTX had an anti-TNF-α effect stimulated 
its application into organ ischemia13,14,19,21-23. 
PTX is a nonselective phosphodiesterase 
inhibitor12,14,18,19 that decreases TNF-alpha and 
NFkB gene transcription13,14,19, affecting multiple 
steps in the cytokine/chemokine pathways and 
exerting beneficial immunomodulatory effects 
on inflammatory conditions directly and 
indirectly12,13,21-27. PTX increased the levels of 
specific cytokines, increased cyclic adenosine 
monophosphate (cAMP) levels and decreased 
TNF-alpha levels, resulting in anti-inflammatory 
and antioxidant properties12,18,21,23,25,26 . These 
biochemical steps may account for the 
observed decrease in tissue damage. Although 
the focus of this study was not to investigate 
the mode of action of PTX, several reports have 
shown that its effects are favorable within the 
model proposed here14,21,22,24-29.
 IPC is a strategy by which tissues are 
subjected to controlled periods of ischemia 
and reperfusion before prolonged IR injury 
and is considered a ubiquitous phenomenon 
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in mammals. The actual mechanism by which 
an episode of brief ischemia and reperfusion 
in an organ or tissue exerts protection against 
a subsequent sustained ischemia-reperfusion 
injury in a remote organ or tissue is currently 
unclear3-11,16,30. In this research, the IPC 
procedures effectively protected the epithelial 
tissue and resulted in minimal smooth 
apical damage, minimal villous edema, and 
mildly dilated capillaries. The morphological 
characteristics of the IPC-treated group were 
similar to the control group. The microscopic 
structure was preserved as seen in the villous 
height and the depth of the crypts.
 Although PTX and IPC separately 
elicited favorable results, the combination of 
these two treatments did not have a synergistic 
effect. Despite sharing some pathways, a 
possible explanation of this result may be the 
fact that PTX and IPC could also act through 
distinct signaling pathways, or at different 
time points, in the activation of factors that 
lead to protection against intestinal ischemia/
reperfusion. Future studies will need to address 
this issue.
 ■ Conclusions
 In a model of short-term evaluation 
of intestinal ischemia and reperfusion, 
pentoxifylline and ischemic preconditioning 
had protective effects against mucosal injury. 
Although both may share common pathways, 
the simultaneous action of both did not provide 
better protection than the employment of each 
one separately.
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